Evolution of postmenopausal hormone therapy between 2002 and 2009

Conclusions: Since the publication of the Women's Health Initiative results, there has been a sustained decrease in hormone therapy claims. The proportional use of low-dose oral and transdermal formulations has increased, but as of 2009, claims for these formulations accounted for approximately one in four total hormone therapy claims.
Source: Menopause - Category: OBGYN Tags: Commemorative Papers Source Type: research